RECRUITING

Using tDCS in Speech-based Stroke Rehabilitation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

Official Title

Using tDCS in Speech-based Stroke Rehabilitation

Quick Facts

Study Start:2019-01-11
Study Completion:2026-10-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03452202

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 99 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Right-handed
  2. * Monolingual (English)
  3. * Single left-hemisphere CVA
  4. * A minimum of six months post-stroke
  5. * Clinical diagnosis of apraxia of speech
  6. * Normal speech perception
  7. * Passing score on the hearing screening.
  1. * Diagnosis of laryngeal voice disorder
  2. * Dysarthria
  3. * History of speech impairment prior to CVA
  4. * Presence of potential tDCS risk factors: damaged skin at site of stimulation;
  5. * Presence of electrically or magnetically activated implant (including pacemaker);
  6. * metal in any part of their body;
  7. * history of medication-resistant epilepsy in the family;
  8. * past history of seizures or unexplained spells of loss of consciousness.

Contacts and Locations

Study Contact

Buchwald Lab
CONTACT
buchwald-lab@nyu.edu

Principal Investigator

Adam Buchwald, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

New York University School of Medicine
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Adam Buchwald, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-01-11
Study Completion Date2026-10-30

Study Record Updates

Study Start Date2019-01-11
Study Completion Date2026-10-30

Terms related to this study

Keywords Provided by Researchers

  • Stroke

Additional Relevant MeSH Terms

  • Apraxia of Speech